Diffusion-MRI in neurodegenerative disorders

Magnetic Resonance Imaging

Volumn 33, Issue 7, 2015, Pages 853-876

  Goveas, Joseph ^a   O'Dwyer, Laurence ^b   Mascalchi, Mario ^c,d   Cosottini, Mirco ^e,f   Diciotti, Stefano ^g   De Santis, Silvia ^h   Passamonti, Luca ^i,j   Tessa, Carlo ^k   Toschi, Nicola ^l,m,n   Giannelli, Marco ^f  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF FLORENCE   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f UNIVERSITY HOSPITAL OF PISA   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h CARDIFF UNIVERSITY   (United Kingdom)

ⁱ CNR   (Italy)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k Versilia Hospital   (Italy)

^l UNIVERSITY OF ROME TOR VERGATA   (Italy)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Degenerative ataxias; Diffusion MRI; Huntington's disease; Parkinson's disease

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; MYELIN BASIC PROTEIN; CONTRAST MEDIUM;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN ATROPHY; CEREBELLUM ATROPHY; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FOLLOW UP; FRACTIONAL ANISOTROPY; FRIEDREICH ATAXIA; HUMAN; HUNTINGTON CHOREA; MEDICAL RESEARCH; NERVE CELL NETWORK; NEUROANATOMY; NEUROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; ALGORITHM; BRAIN; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; PATHOLOGY; PROCEDURES; REPRODUCIBILITY;

ALGORITHMS; BRAIN; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; NEURODEGENERATIVE DISEASES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84930537081     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2015.04.006     Document Type: Review

References (375)

1. Einstein A., Fürth R. Investigations on the theory of Brownian movement 1956, Dover Publications, New York (NY).
2. Johansen-Berg H., Behrens T.E.J. Diffusion MRI: from quantitative measurement to in-vivo neuroanatomy 2009, Elsevier Science.
3. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed 2002, 15(7-8):435-455. 10.1002/nbm.782.
4. Jones D.K. Diffusion MRI: theory, methods, and applications 2010, Oxford University Press, USA. 10.1093/med/9780195369779.001.0001.
5. Tournier J.D., Mori S., Leemans A. Diffusion tensor imaging and beyond. Magn Reson Med 2011, 65(6):1532-1556. 10.1002/mrm.22924.
6. Brodaty H., Breteler M.M., Dekosky S.T., Dorenlot P., Fratiglioni L., Hock C., et al. The world of dementia beyond 2020. J Am Geriatr Soc 2011, 59(5):923-927. 10.1111/j.1532-5415.2011.03365.x.
7. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7(3):270-279. 10.1016/j.jalz.2011.03.008.
8. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7(3):280-292. 10.1016/j.jalz.2011.03.003.
9. Brun A., Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986, 19(3):253-262. 10.1002/ana.410190306.
10. Gouw A.A., Seewann A., Vrenken H., van der Flier W.M., Rozemuller J.M., Barkhof F., et al. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 2008, 131(Pt 12):3286-3298. 10.1093/brain/awn265.
11. Scheltens P., Barkhof F., Leys D., Wolters E.C., Ravid R., Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 1995, 45(5):883-888. 10.1212/WNL.45.5.883.
12. Sjobeck M., Haglund M., Englund E. White matter mapping in Alzheimer's disease: a neuropathological study. Neurobiol Aging 2006, 27(5):673-680. 10.1016/j.neurobiolaging.2005.03.007.
13. Roher A.E., Weiss N., Kokjohn T.A., Kuo Y.M., Kalback W., Anthony J., et al. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 2002, 41(37):11080-11090. 10.1021/bi026173d.
14. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 2004, 25(1):5-18. [author reply 49-62]. 10.1016/j.neurobiolaging.2003.03.001.
15. Reisberg B., Franssen E.H., Souren L.E., Auer S.R., Akram I., Kenowsky S. Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: management and treatment import. Am J Alzheimers Dis Other Demen 2002, 17(4):202-212. 10.1177/153331750201700411.
16. Bartzokis G., Lu P.H., Mintz J. Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimers Dement 2007, 3(2):122-125. 10.1016/j.jalz.2007.01.019.
17. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005, 6(11):889-898. 10.1038/nrn1788.
18. Mori S. Introduction to diffusion tensor imaging 2007, Elsevier Science.
19. Teipel S.J., Grothe M., Lista S., Toschi N., Garaci F.G., Hampel H. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. Med Clin North Am 2013, 97(3):399-424. 10.1016/j.mcna.2012.12.013.
20. Teipel S.J., Meindl T., Grinberg L., Heinsen H., Hampel H. Novel MRI techniques in the assessment of dementia. Eur J Nucl Med Mol Imaging 2008, 35(Suppl. 1):S58-S69. 10.1007/s00259-007-0703-z.
21. Teipel S.J., Wegrzyn M., Meindl T., Frisoni G., Bokde A.L., Fellgiebel A., et al. Anatomical MRI and DTI in the diagnosis of Alzheimer's disease: a European multicenter study. J Alzheimers Dis 2012, (31 Suppl. 3):S33-S47. 10.3233/JAD-2012-112118.
22. Lista S., Garaci F.G., Toschi N., Hampel H. Imaging epigenetics in Alzheimer's disease. Curr Pharm Des 2013, 19(36):6393-6415. 10.2174/13816128113199990370.
23. Stricker N.H., Schweinsburg B.C., Delano-Wood L., Wierenga C.E., Bangen K.J., Haaland K.Y., et al. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis. Neuroimage 2009, 45(1):10-16. 10.1016/j.neuroimage.2008.11.027.
24. Choi S.J., Lim K.O., Monteiro I., Reisberg B. Diffusion tensor imaging of frontal white matter microstructure in early Alzheimer's disease: a preliminary study. J Geriatr Psychiatry Neurol 2005, 18(1):12-19. 10.1177/0891988704271763.
25. Huang J., Friedland R.P., Auchus A.P. Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: preliminary evidence of axonal degeneration in the temporal lobe. AJNR Am J Neuroradiol 2007, 28(10):1943-1948. 10.3174/ajnr.A0700.
26. Bozzali M., Falini A., Franceschi M., Cercignani M., Zuffi M., Scotti G., et al. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002, 72(6):742-746. 10.1136/jnnp.72.6.742.
27. Sexton C.E., Kalu U.G., Filippini N., Mackay C.E., Ebmeier K.P. A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2011, 32(12):2322.e5-2322.e18. 10.1016/j.neurobiolaging.2010.05.019.
28. Mielke M.M., Okonkwo O.C., Oishi K., Mori S., Tighe S., Miller M.I., et al. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease. Alzheimers Dement 2012, 8(2):105-113. 10.1016/j.jalz.2011.05.2416.
29. Nowrangi M.A., Lyketsos C.G., Leoutsakos J.M., Oishi K., Albert M., Mori S., et al. Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement 2012, 10.1016/j.jalz.2012.05.2186.
30. Stahl R., Dietrich O., Teipel S.J., Hampel H., Reiser M.F., Schoenberg S.O. White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 2007, 243(2):483-492. 10.1148/radiol.2432051714.
31. Head D., Buckner R.L., Shimony J.S., Williams L.E., Akbudak E., Conturo T.E., et al. Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. Cereb Cortex 2004, 14(4):410-423. 10.1093/cercor/bhh003.
32. Zhang Y., Schuff N., Jahng G.H., Bayne W., Mori S., Schad L., et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007, 68(1):13-19. 10.1212/01.wnl.0000250326.77323.01.
33. Kavcic V., Ni H., Zhu T., Zhong J., Duffy C.J. White matter integrity linked to functional impairments in aging and early Alzheimer's disease. Alzheimers Dement 2008, 4(6):381-389. 10.1016/j.jalz.2008.07.001.
34. Fellgiebel A., Schermuly I., Gerhard A., Keller I., Albrecht J., Weibrich C., et al. Functional relevant loss of long association fibre tracts integrity in early Alzheimer's disease. Neuropsychologia 2008, 46(6):1698-1706. 10.1016/j.neuropsychologia.2007.12.010.
35. Stebbins G.T., Murphy C.M. Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Behav Neurol 2009, 21(1):39-49. 10.3233/BEN-2009-0234.
36. Damoiseaux J.S., Smith S.M., Witter M.P., Sanz-Arigita E.J., Barkhof F., Scheltens P., et al. White matter tract integrity in aging and Alzheimer's disease. Hum Brain Mapp 2009, 30(4):1051-1059. 10.1002/hbm.20563.
37. Mielke M.M., Kozauer N.A., Chan K.C., George M., Toroney J., Zerrate M., et al. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage 2009, 46(1):47-55. 10.1016/j.neuroimage.2009.01.054.
38. Medina D., DeToledo-Morrell L., Urresta F., Gabrieli J.D., Moseley M., Fleischman D., et al. White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol Aging 2006, 27(5):663-672. 10.1016/j.neurobiolaging.2005.03.026.
39. Rose S.E., McMahon K.L., Janke A.L., O'Dowd B., de Zubicaray G., Strudwick M.W., et al. Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment. J Neurol Neurosurg Psychiatry 2006, 77(10):1122-1128. 10.1136/jnnp.2005.074336.
40. Acosta-Cabronero J., Williams G.B., Pengas G., Nestor P.J. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain 2010, 133(Pt 2):529-539. 10.1093/brain/awp257.
41. Fellgiebel A., Yakushev I. Diffusion tensor imaging of the hippocampus in MCI and early Alzheimer's disease. J Alzheimers Dis 2011, 26(Suppl. 3):257-262. 10.3233/JAD-2011-0001.
42. Budde M.D., Xie M., Cross A.H., Song S.K. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis. J Neurosci 2009, 29(9):2805-2813. 10.1523/JNEUROSCI.4605-08.2009.
43. Song S.K., Sun S.W., Ju W.K., Lin S.J., Cross A.H., Neufeld A.H. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003, 20(3):1714-1722. 10.1016/j.neuroimage.2003.07.005.
44. Smith S.M., Jenkinson M., Johansen-Berg H., Rueckert D., Nichols T.E., Mackay C.E., et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006, 31(4):1487-1505. 10.1016/j.neuroimage.2006.02.024.
45. Bosch B., Arenaza-Urquijo E.M., Rami L., Sala-Llonch R., Junque C., Sole-Padulles C., et al. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiol Aging 2012, 33(1):61-74. 10.1016/j.neurobiolaging.2010.02.004.
46. Di Paola M., Di Iulio F., Cherubini A., Blundo C., Casini A.R., Sancesario G., et al. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study. Neurology 2010, 74(14):1136-1142. 10.1212/WNL.0b013e3181d7d8cb.
47. O'Dwyer L., Lamberton F., Bokde A.L., Ewers M., Faluyi Y.O., Tanner C., et al. Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer's disease. PLoS One 2011, 6(6):e21745. 10.1371/journal.pone.0021745.
48. Liu Y., Spulber G., Lehtimaki K.K., Kononen M., Hallikainen I., Grohn H., et al. Diffusion tensor imaging and tract-based spatial statistics in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 2011, 32(9):1558-1571. 10.1016/j.neurobiolaging.2009.10.006.
49. Acosta-Cabronero J., Alley S., Williams G.B., Pengas G., Nestor P.J. Diffusion tensor metrics as biomarkers in Alzheimer's disease. PLoS One 2012, 7(11):e49072. 10.1371/journal.pone.0049072.
50. Agosta F., Pievani M., Sala S., Geroldi C., Galluzzi S., Frisoni G.B., et al. White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 2011, 258(3):853-863. 10.1148/radiol.10101284.
51. Alves G.S., O'Dwyer L., Jurcoane A., Oertel-Knochel V., Knochel C., Prvulovic D., et al. Different patterns of white matter degeneration using multiple diffusion indices and volumetric data in mild cognitive impairment and Alzheimer patients. PLoS One 2012, 7(12):e52859. 10.1371/journal.pone.0052859.
52. Song S.K., Kim J.H., Lin S.J., Brendza R.P., Holtzman D.M. Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition. Neurobiol Dis 2004, 15(3):640-647. 10.1016/j.nbd.2003.12.003.
53. Ghoshal N., Garcia-Sierra F., Wuu J., Leurgans S., Bennett D.A., Berry R.W., et al. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol 2002, 177(2):475-493. 10.1006/exnr.2002.8014.
54. Kalus P., Slotboom J., Gallinat J., Mahlberg R., Cattapan-Ludewig K., Wiest R., et al. Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia. Neuroimage 2006, 30(3):713-720. 10.1016/j.neuroimage.2005.10.035.
55. Kanaan N.M., Pigino G.F., Brady S.T., Lazarov O., Binder L.I., Morfini G.A. Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system. Exp Neurol 2013, 246:44-53. 10.1016/j.expneurol.2012.06.003.
56. Vana L., Kanaan N.M., Ugwu I.C., Wuu J., Mufson E.J., Binder L.I. Progression of tau pathology in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. Am J Pathol 2011, 179(5):2533-2550. 10.1016/j.ajpath.2011.07.044.
57. van Bruggen T., Stieltjes B., Thomann P.A., Parzer P., Meinzer H.P., Fritzsche K.H. Do Alzheimer-specific microstructural changes in mild cognitive impairment predict conversion?. Psychiatry Res 2012, 203(2-3):184-193. 10.1016/j.pscychresns.2011.12.003.
58. Selnes P., Aarsland D., Bjornerud A., Gjerstad L., Wallin A., Hessen E., et al. Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment. J Alzheimers Dis 2013, 33(3):723-736. 10.3233/JAD-2012-121603.
59. Basser P.J., Jones D.K. Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed 2002, 15(7-8):456-467. 10.1002/nbm.783.
60. Grinberg F., Farrher E., Kaffanke J., Oros-Peusquens A.M., Shah N.J. Non-Gaussian diffusion in human brain tissue at high b-factors as examined by a combined diffusion kurtosis and biexponential diffusion tensor analysis. Neuroimage 2011, 57(3):1087-1102. 10.1016/j.neuroimage.2011.04.050.
61. Clark C.A., Le Bihan D. Water diffusion compartmentation and anisotropy at high b values in the human brain. Magn Reson Med 2000, 44(6):852-859. 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A.
62. De Santis S., Gabrielli A., Palombo M., Maraviglia B., Capuani S. Non-Gaussian diffusion imaging: a brief practical review. Magn Reson Imaging 2011, 29(10):1410-1416. 10.1016/j.mri.2011.04.006.
63. Bester M., Jensen J., Babb J., Tabesh A., Miles L., Herbert J., et al. Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis. Mult Scler 2014, 10.1177/1352458514556295.
64. Wu E.X., Cheung M.M. MR diffusion kurtosis imaging for neural tissue characterization. NMR Biomed 2010, 23(7):836-848. 10.1002/nbm.1506.
65. Van Cauter S., Veraart J., Sijbers J., Peeters R.R., Himmelreich U., De Keyzer F., et al. Gliomas: diffusion kurtosis MR imaging in grading. Radiology 2012, 263(2):492-501. 10.1148/radiol.12110927.
66. Lee C.Y., Tabesh A., Benitez A., Helpern J.A., Jensen J.H., Bonilha L. Microstructural integrity of early- versus late-myelinating white matter tracts in medial temporal lobe epilepsy. Epilepsia 2013, 54(10):1801-1809. 10.1111/epi.12353.
67. Hui E.S., Fieremans E., Jensen J.H., Tabesh A., Feng W., Bonilha L., et al. Stroke assessment with diffusional kurtosis imaging. Stroke 2012, 43(11):2968-2973. 10.1161/STROKEAHA.112.657742.
68. Blockx I., De Groof G., Verhoye M., Van Audekerke J., Raber K., Poot D., et al. Microstructural changes observed with DKI in a transgenic Huntington rat model: evidence for abnormal neurodevelopment. Neuroimage 2012, 59(2):957-967. 10.1016/j.neuroimage.2011.08.062.
69. Falangola M.F., Jensen J.H., Tabesh A., Hu C., Deardorff R.L., Babb J.S., et al. Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease. Magn Reson Imaging 2013, 31(6):840-846. 10.1016/j.mri.2013.02.008.
70. Jensen J.H., Helpern J.A., Ramani A., Lu H., Kaczynski K. Diffusional kurtosis imaging: the quantification of non-Gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 2005, 53(6):1432-1440. 10.1002/mrm.20508.
71. Jensen J.H., Helpern J.A. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed 2010, 23(7):698-710. 10.1002/nbm.1518.
72. Steven A.J., Zhuo J., Melhem E.R. Diffusion kurtosis imaging: an emerging technique for evaluating the microstructural environment of the brain. AJR Am J Roentgenol 2014, 202(1):W26-W33. 10.2214/AJR.13.11365.
73. Gong N.J., Wong C.S., Chan C.C., Leung L.M., Chu Y.C. Aging in deep gray matter and white matter revealed by diffusional kurtosis imaging. Neurobiol Aging 2014, 35(10):2203-2216. 10.1016/j.neurobiolaging.2014.03.011.
74. Gao J., Feng S.T., Wu B., Gong N., Lu M., Wu P.M., et al. Microstructural brain abnormalities of children of idiopathic generalized epilepsy with generalized tonic-clonic seizure: a voxel-based diffusional kurtosis imaging study. J Magn Reson Imaging 2015, 41(4):1088-1095. 10.1002/jmri.24647.
75. Bonilha L., Lee C.Y., Jensen J.H., Tabesh A., Spampinato M.V., Edwards J.C., et al. Altered microstructure in temporal lobe epilepsy: a diffusional kurtosis imaging study. AJNR Am J Neuroradiol 2015, 36(4):719-724. 10.3174/ajnr.A4185.
76. Gao Y., Zhang Y., Wong C.S., Wu P.M., Zhang Z., Gao J., et al. Diffusion abnormalities in temporal lobes of children with temporal lobe epilepsy: a preliminary diffusional kurtosis imaging study and comparison with diffusion tensor imaging. NMR Biomed 2012, 25(12):1369-1377. 10.1002/nbm.2809.
77. Jespersen S.N., Leigland L.A., Cornea A., Kroenke C.D. Determination of axonal and dendritic orientation distributions within the developing cerebral cortex by diffusion tensor imaging. IEEE Trans Med Imaging 2012, 31(1):16-32. 10.1109/TMI.2011.2162099.
78. Fieremans E., Jensen J.H., Helpern J.A. White matter characterization with diffusional kurtosis imaging. Neuroimage 2011, 58(1):177-188. 10.1016/j.neuroimage.2011.06.006.
79. Hui E.S., Russell Glenn G., Helpern J.A., Jensen J.H. Kurtosis analysis of neural diffusion organization. Neuroimage 2015, 106:391-403. 10.1016/j.neuroimage.2014.11.015.
80. Jelescu I.O., Veraart J., Adisetiyo V., Milla S.S., Novikov D.S., Fieremans E. One diffusion acquisition and different white matter models: how does microstructure change in human early development based on WMTI and NODDI?. Neuroimage 2015, 107:242-256. 10.1016/j.neuroimage.2014.12.009.
81. Gong N.J., Wong C.S., Chan C.C., Leung L.M., Chu Y.C. Correlations between microstructural alterations and severity of cognitive deficiency in Alzheimer's disease and mild cognitive impairment: a diffusional kurtosis imaging study. Magn Reson Imaging 2013, 31(5):688-694. 10.1016/j.mri.2012.10.027.
82. Fieremans E., Benitez A., Jensen J.H., Falangola M.F., Tabesh A., Deardorff R.L., et al. Novel white matter tract integrity metrics sensitive to Alzheimer disease progression. AJNR Am J Neuroradiol 2013, 10.3174/ajnr.A3553.
83. Zarei M., Damoiseaux J.S., Morgese C., Beckmann C.F., Smith S.M., Matthews P.M., et al. Regional white matter integrity differentiates between vascular dementia and Alzheimer disease. Stroke 2009, 40(3):773-779. 10.1161/STROKEAHA.108.530832.
84. Kiuchi K., Morikawa M., Taoka T., Nagashima T., Yamauchi T., Makinodan M., et al. Abnormalities of the uncinate fasciculus and posterior cingulate fasciculus in mild cognitive impairment and early Alzheimer's disease: a diffusion tensor tractography study. Brain Res 2009, 1287:184-191. 10.1016/j.brainres.2009.06.052.
85. Bozzali M., Parker G.J., Serra L., Embleton K., Gili T., Perri R., et al. Anatomical connectivity mapping: a new tool to assess brain disconnection in Alzheimer's disease. Neuroimage 2011, 54(3):2045-2051. 10.1016/j.neuroimage.2010.08.069.
86. Bozzali M., Giulietti G., Basile B., Serra L., Spano B., Perri R., et al. Damage to the cingulum contributes to Alzheimer's disease pathophysiology by deafferentation mechanism. Hum Brain Mapp 2012, 33(6):1295-1308. 10.1002/hbm.21287.
87. Fischer F.U., Scheurich A., Wegrzyn M., Schermuly I., Bokde A.L., Kloppel S., et al. Automated tractography of the cingulate bundle in Alzheimer's disease: a multicenter DTI study. J Magn Reson Imaging 2012, 36(1):84-91. 10.1002/jmri.23621.
88. Douaud G., Jbabdi S., Behrens T.E., Menke R.A., Gass A., Monsch A.U., et al. DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage 2011, 55(3):880-890. 10.1016/j.neuroimage.2010.12.008.
89. Pievani M., Agosta F., Pagani E., Canu E., Sala S., Absinta M., et al. Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp 2010, 31(12):1862-1875. 10.1002/hbm.20978.
90. Nezamzadeh M., Wedeen V.J., Wang R., Zhang Y., Zhan W., Young K., et al. In-vivo investigation of the human cingulum bundle using the optimization of MR diffusion spectrum imaging. Eur J Radiol 2010, 75(1):e29-e36. 10.1016/j.ejrad.2009.06.019.
91. Pfefferbaum A., Adalsteinsson E., Sullivan E.V. Frontal circuitry degradation marks healthy adult aging: evidence from diffusion tensor imaging. Neuroimage 2005, 26(3):891-899. 10.1016/j.neuroimage.2005.02.034.
92. Sullivan E.V., Pfefferbaum A. Diffusion tensor imaging and aging. Neurosci Biobehav Rev 2006, 30(6):749-761. 10.1016/j.neubiorev.2006.06.002.
93. Honea R.A., Vidoni E., Harsha A., Burns J.M. Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J Alzheimers Dis 2009, 18(3):553-564. 10.3233/JAD-2009-1163.
94. Persson J., Lind J., Larsson A., Ingvar M., Cruts M., Van Broeckhoven C., et al. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?. Neurology 2006, 66(7):1029-1033. 10.1212/01.wnl.0000204180.25361.48.
95. Ryan L., Walther K., Bendlin B.B., Lue L.F., Walker D.G., Glisky E.L. Age-related differences in white matter integrity and cognitive function are related to APOE status. Neuroimage 2011, 54(2):1565-1577. 10.1016/j.neuroimage.2010.08.052.
96. Heise V., Filippini N., Ebmeier K.P., Mackay C.E. The APOE varepsilon4 allele modulates brain white matter integrity in healthy adults. Mol Psychiatry 2011, 16(9):908-916. 10.1038/mp.2010.90.
97. Bendlin B.B., Ries M.L., Canu E., Sodhi A., Lazar M., Alexander A.L., et al. White matter is altered with parental family history of Alzheimer's disease. Alzheimers Dement 2010, 6(5):394-403. 10.1016/j.jalz.2009.11.003.
98. Bendlin B.B., Carlsson C.M., Johnson S.C., Zetterberg H., Blennow K., Willette A.A., et al. CSF T-Tau/Abeta42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease. PLoS One 2012, 7(6):e37720. 10.1371/journal.pone.0037720.
99. Adluru N., Destiche D.J., Lu S.Y., Doran S.T., Birdsill A.C., Melah K.E., et al. White matter microstructure in late middle-age: effects of apolipoprotein E4 and parental family history of Alzheimer's disease. Neuroimage Clin 2014, 4:730-742. 10.1016/j.nicl.2014.04.008.
100. Racine A.M., Adluru N., Alexander A.L., Christian B.T., Okonkwo O.C., Oh J., et al. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: a multimodal imaging investigation. Neuroimage Clin 2014, 4:604-614. 10.1016/j.nicl.2014.02.001.
101. Sporns O. Networks of the brain 2010, MIT Press.
102. Rubinov M., Sporns O. Complex network measures of brain connectivity: uses and interpretations. Neuroimage 2010, 52(3):1059-1069. 10.1016/j.neuroimage.2009.10.003.
103. Lo C.Y., Wang P.N., Chou K.H., Wang J., He Y., Lin C.P. Diffusion tensor tractography reveals abnormal topological organization in structural cortical networks in Alzheimer's disease. J Neurosci 2010, 30(50):16876-16885. 10.1523/JNEUROSCI.4136-10.2010.
104. Shu N., Liang Y., Li H., Zhang J., Li X., Wang L., et al. Disrupted topological organization in white matter structural networks in amnestic mild cognitive impairment: relationship to subtype. Radiology 2012, 265(2):518-527. 10.1148/radiol.12112361.
105. Brown J.A., Terashima K.H., Burggren A.C., Ercoli L.M., Miller K.J., Small G.W., et al. Brain network local interconnectivity loss in aging APOE-4 allele carriers. Proc Natl Acad Sci U S A 2011, 108(51):20760-20765. 10.1073/pnas.1109038108.
106. Prescott J.W., Guidon A., Doraiswamy P.M., Roy Choudhury K., Liu C., Petrella J.R. Alzheimer's Disease Neuroimaging I. The Alzheimer structural connectome: changes in cortical network topology with increased amyloid plaque burden. Radiology 2014, 273(1):175-184. 10.1148/radiol.14132593.
107. O'Dwyer L., Lamberton F., Bokde A.L., Ewers M., Faluyi Y.O., Tanner C., et al. Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairment. PLoS One 2012, 7(2):e32441. 10.1371/journal.pone.0032441.
108. Wee C.Y., Yap P.T., Zhang D., Denny K., Browndyke J.N., Potter G.G., et al. Identification of MCI individuals using structural and functional connectivity networks. Neuroimage 2012, 59(3):2045-2056. 10.1016/j.neuroimage.2011.10.015.
109. Diciotti S., Ciulli S., Mascalchi M., Giannelli M., Toschi N. The "peeking" effect in supervised feature selection on diffusion tensor imaging data. AJNR Am J Neuroradiol 2013, 34(9):E107. 10.3174/ajnr.A3685.
110. de Rijk M.C., Launer L.J., Berger K., Breteler M.M., Dartigues J.F., Baldereschi M., et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000, 54(11 Suppl. 5):S21-S23. 10.1212/WNL.54.11.21A.
111. Lilienfeld D.E., Perl D.P. Projected neurodegenerative disease mortality in the United States, 1990-2040. Neuroepidemiology 1993, 12(4):219-228. 10.1159/000110320.
112. Braak H., Ghebremedhin E., Rub U., Bratzke H., Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004, 318(1):121-134. 10.1007/s00441-004-0956-9.
113. Aarsland D., Andersen K., Larsen J.P., Lolk A., Nielsen H., Kragh-Sorensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 2001, 56(6):730-736. 10.1212/WNL.56.6.730.
114. Williams-Gray C.H., Foltynie T., Brayne C.E., Robbins T.W., Barker R.A. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007, 130(Pt 7):1787-1798. 10.1093/brain/awm111.
115. Mascalchi M., Vella A., Ceravolo R. Movement disorders: role of imaging in diagnosis. J Magn Reson Imaging 2012, 35(2):239-256. 10.1002/jmri.22825.
116. Tofts P. Quantitative MRI of the brain: measuring changes caused by disease 2003, Wiley. 10.1002/0470869526.
117. Nicoletti G., Lodi R., Condino F., Tonon C., Fera F., Malucelli E., et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006, 129(Pt 10):2679-2687. 10.1093/brain/awl166.
118. Seppi K., Schocke M.F., Esterhammer R., Kremser C., Brenneis C., Mueller J., et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003, 60(6):922-927. 10.1212/01.WNL.0000049911.91657.9D.
119. Schocke M.F., Seppi K., Esterhammer R., Kremser C., Mair K.J., Czermak B.V., et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 2004, 21(4):1443-1451. 10.1016/j.neuroimage.2003.12.005.
120. Wang P.S., Wu H.M., Lin C.P., Soong B.W. Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology 2011, 53(7):471-481. 10.1007/s00234-010-0757-7.
121. Boelmans K., Bodammer N.C., Suchorska B., Kaufmann J., Ebersbach G., Heinze H.J., et al. Diffusion tensor imaging of the corpus callosum differentiates corticobasal syndrome from Parkinson's disease. Parkinsonism Relat Disord 2010, 16(8):498-502. 10.1016/j.parkreldis.2010.05.006.
122. Prodoehl J., Li H., Planetta P.J., Goetz C.G., Shannon K.M., Tangonan R., et al. Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor. Mov Disord 2013, 28(13):1816-1822. 10.1002/mds.25491.
123. Nair S.R., Tan L.K., Mohd Ramli N., Lim S.Y., Rahmat K., Mohd Nor H. A decision tree for differentiating multiple system atrophy from Parkinson's disease using 3-T MR imaging. Eur Radiol 2013, 23(6):1459-1466. 10.1007/s00330-012-2759-9.
124. Yoshikawa K., Nakata Y., Yamada K., Nakagawa M. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004, 75(3):481-484. 10.1136/jnnp.2003.021873.
125. Chan L.L., Rumpel H., Yap K., Lee E., Loo H.V., Ho G.L., et al. Case control study of diffusion tensor imaging in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007, 78(12):1383-1386. 10.1136/jnnp.2007.121525.
126. Vaillancourt D.E., Spraker M.B., Prodoehl J., Abraham I., Corcos D.M., Zhou X.J., et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009, 72(16):1378-1384. 10.1212/01.wnl.0000340982.01727.6e.
127. Menke R.A., Scholz J., Miller K.L., Deoni S., Jbabdi S., Matthews P.M., et al. MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage 2009, 47(2):435-441. 10.1016/j.neuroimage.2009.05.017.
128. Dexter D.T., Wells F.R., Lees A.J., Agid F., Agid Y., Jenner P., et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 1989, 52(6):1830-1836. 10.1111/j.1471-4159.1989.tb07264.x.
129. Earle K.M. Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. J Neuropathol Exp Neurol 1968, 27(1):1-14. 10.1097/00005072-196801000-00001.
130. Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G.P., Hebenstreit G., et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 1988, 74(3):199-205. 10.1007/BF01244786.
131. Haacke E.M., Cheng N.Y., House M.J., Liu Q., Neelavalli J., Ogg R.J., et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005, 23(1):1-25. 10.1016/j.mri.2004.10.001.
132. Peran P., Cherubini A., Assogna F., Piras F., Quattrocchi C., Peppe A., et al. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 2010, 133(11):3423-3433. 10.1093/brain/awq212.
133. Du G., Lewis M.M., Styner M., Shaffer M.L., Sen S., Yang Q.X., et al. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov Disord 2011, 26(9):1627-1632. 10.1002/mds.23643.
134. Du G., Lewis M.M., Sen S., Wang J., Shaffer M.L., Styner M., et al. Imaging nigral pathology and clinical progression in Parkinson's disease. Mov Disord 2012, 27(13):1636-1643. 10.1002/mds.25182.
135. Aquino D., Contarino V., Albanese A., Minati L., Farina L., Grisoli M., et al. Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease. Neurol Sci 2014, 35(5):753-758. 10.1007/s10072-013-1595-2.
136. Schwarz S.T., Abaei M., Gontu V., Morgan P.S., Bajaj N., Auer D.P. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: a region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin 2013, 3:481-488. 10.1016/j.nicl.2013.10.006.
137. Tessa C., Giannelli M., Della Nave R., Lucetti C., Berti C., Ginestroni A., et al. A whole-brain analysis in de novo Parkinson disease. AJNR Am J Neuroradiol 2008, 29(4):674-680. 10.3174/ajnr.A0900.
138. Zhang K., Yu C., Zhang Y., Wu X., Zhu C., Chan P., et al. Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson's disease. Eur J Radiol 2011, 77(2):269-273. 10.1016/j.ejrad.2009.07.032.
139. Karagulle Kendi A.T., Lehericy S., Luciana M., Ugurbil K., Tuite P. Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol 2008, 29(3):501-505. 10.3174/ajnr.A0850.
140. Rae C.L., Correia M.M., Altena E., Hughes L.E., Barker R.A., Rowe J.B. White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function. Neuroimage 2012, 62(3):1675-1684. 10.1016/j.neuroimage.2012.06.012.
141. Zhan W., Kang G.A., Glass G.A., Zhang Y., Shirley C., Millin R., et al. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov Disord 2012, 27(1):90-97. 10.1002/mds.23917.
142. Ibarretxe-Bilbao N., Junque C., Marti M.J., Valldeoriola F., Vendrell P., Bargallo N., et al. Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: a voxel-based diffusion tensor imaging study. Mov Disord 2010, 25(12):1888-1894. 10.1002/mds.23208.
143. Rolheiser T.M., Fulton H.G., Good K.P., Fisk J.D., McKelvey J.R., Scherfler C., et al. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease. J Neurol 2011, 258(7):1254-1260. 10.1007/s00415-011-5915-2.
144. Scherfler C., Schocke M.F., Seppi K., Esterhammer R., Brenneis C., Jaschke W., et al. Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain 2006, 129(Pt 2):538-542. 10.1093/brain/awh674.
145. Kamagata K., Motoi Y., Abe O., Shimoji K., Hori M., Nakanishi A., et al. White matter alteration of the cingulum in Parkinson disease with and without dementia: evaluation by diffusion tensor tract-specific analysis. AJNR Am J Neuroradiol 2012, 33(5):890-895. 10.3174/ajnr.A2860.
146. Hattori T., Orimo S., Aoki S., Ito K., Abe O., Amano A., et al. Cognitive status correlates with white matter alteration in Parkinson's disease. Hum Brain Mapp 2012, 33(3):727-739. 10.1002/hbm.21245.
147. Modrego P.J., Fayed N., Artal J., Olmos S. Correlation of findings in advanced MRI techniques with global severity scales in patients with Parkinson disease. Acad Radiol 2011, 18(2):235-241. 10.1016/j.acra.2010.09.022.
148. Scherfler C., Esterhammer R., Nocker M., Mahlknecht P., Stockner H., Warwitz B., et al. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease. Brain 2013, 136(Pt 10):3028-3037. 10.1093/brain/awt234.
149. Melzer T.R., Watts R., MacAskill M.R., Pitcher T.L., Livingston L., Keenan R.J., et al. White matter microstructure deteriorates across cognitive stages in Parkinson disease. Neurology 2013, 80(20):1841-1849. 10.1212/WNL.0b013e3182929f62.
150. Agosta F., Canu E., Stefanova E., Sarro L., Tomic A., Spica V., et al. Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage. Hum Brain Mapp 2014, 35(5):1921-1929. 10.1002/hbm.22302.
151. Carlesimo G.A., Piras F., Assogna F., Pontieri F.E., Caltagirone C., Spalletta G. Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study. Neurology 2012, 78(24):1939-1945. 10.1212/WNL.0b013e318259e1c5.
152. Baggio H.C., Segura B., Ibarretxe-Bilbao N., Valldeoriola F., Marti M.J., Compta Y., et al. Structural correlates of facial emotion recognition deficits in Parkinson's disease patients. Neuropsychologia 2012, 50(8):2121-2128. 10.1016/j.neuropsychologia.2012.05.020.
153. Bertrand J.A., Bedetti C., Postuma R.B., Monchi O., Genier Marchand D., Jubault T., et al. Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations. Mov Disord 2012, 27(14):1781-1788. 10.1002/mds.25272.
154. Feldmann A., Illes Z., Kosztolanyi P., Illes E., Mike A., Kover F., et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study. Mov Disord 2008, 23(1):42-46. 10.1002/mds.21765.
155. Kostic V.S., Agosta F., Petrovic I., Galantucci S., Spica V., Jecmenica-Lukic M., et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 2010, 75(10):857-863. 10.1212/WNL.0b013e3181f11c1d.
156. Surdhar I., Gee M., Bouchard T., Coupland N., Malykhin N., Camicioli R. Intact limbic-prefrontal connections and reduced amygdala volumes in Parkinson's disease with mild depressive symptoms. Parkinsonism Relat Disord 2012, 18(7):809-813. 10.1016/j.parkreldis.2012.03.008.
157. Wang J.J., Lin W.Y., Lu C.S., Weng Y.H., Ng S.H., Wang C.H., et al. Parkinson disease: diagnostic utility of diffusion kurtosis imaging. Radiology 2011, 261(1):210-217. 10.1148/radiol.11102277.
158. Kamagata K., Tomiyama H., Motoi Y., Kano M., Abe O., Ito K., et al. Diffusional kurtosis imaging of cingulate fibers in Parkinson disease: comparison with conventional diffusion tensor imaging. Magn Reson Imaging 2013, 31(9):1501-1506. 10.1016/j.mri.2013.06.009.
159. Kamagata K., Tomiyama H., Hatano T., Motoi Y., Abe O., Shimoji K., et al. A preliminary diffusional kurtosis imaging study of Parkinson disease: comparison with conventional diffusion tensor imaging. Neuroradiology 2014, 56(3):251-258. 10.1007/s00234-014-1327-1.
160. Giannelli M., Toschi N., Passamonti L., Mascalchi M., Diciotti S., Tessa C. Diffusion kurtosis and diffusion-tensor MR imaging in Parkinson disease. Radiology 2012, 265(2):645-646. 10.1148/radiol.12121036.
161. Strong M., Rosenfeld J. Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4(3):136-143. 10.1080/14660820310011250.
162. Charcot J.M. Des amyotrophies spinales chroniques. Progres Medical 1874, 2:573-574.
163. Musaro A. State of the art and the dark side of amyotrophic lateral sclerosis. World J Biol Chem 2010, 1(5):62-68. 10.4331/wjbc.v1.i5.62.
164. Phukan J., Pender N.P., Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 2007, 6(11):994-1003. 10.1016/S1474-4422(07)70265-X.
165. Geser F., Brandmeir N.J., Kwong L.K., Martinez-Lage M., Elman L., McCluskey L., et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 2008, 65(5):636-641. 10.1001/archneur.65.5.636.
166. Nakano I. Frontotemporal dementia with motor neuron disease (amyotrophic lateral sclerosis with dementia). Neuropathology 2000, 20(1):68-75. 10.1046/j.1440-1789.2000.00272.x.
167. Neumann M. Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci 2009, 10(1):232-246. 10.3390/ijms10010232.
168. Ince P.G., Evans J., Knopp M., Forster G., Hamdalla H.H., Wharton S.B., et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003, 60(8):1252-1258. 10.1212/01.WNL.0000058901.75728.4E.
169. Ince P.G., Lowe J., Shaw P.J. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998, 24(2):104-117. 10.1046/j.1365-2990.1998.00108.x.
170. Brownell B., Oppenheimer D.R., Hughes J.T. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 1970, 33(3):338-357. 10.1136/jnnp.33.3.338.
171. Chan S., Kaufmann P., Shungu D.C., Mitsumoto H. Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Neuroimaging Clin N Am 2003, 13(2):307-326. 10.1016/S1052-5149(03)00018-2.
172. Filippi M., Agosta F., Abrahams S., Fazekas F., Grosskreutz J., Kalra S., et al. European Federation of Neurological S. EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol 2010, 17(4):526-533. 10.1111/j.1468-1331.2010.02951.x.
173. Turner M.R. MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers?. Biomark Med 2011, 5(1):79-81. 10.2217/bmm.10.120.
174. Cheung G., Gawel M.J., Cooper P.W., Farb R.I., Ang L.C., Gawal M.J. Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 1995, 194(1):263-270. 10.1148/radiology.194.1.7997565.
175. Hecht M.J., Fellner F., Fellner C., Hilz M.J., Neundorfer B., Heuss D. Hyperintense and hypointense MRI signals of the precentral gyrus and corticospinal tract in ALS: a follow-up examination including FLAIR images. J Neurol Sci 2002, 199(1-2):59-65. 10.1016/S0022-510X(02)00104-1.
176. Agosta F., Pagani E., Rocca M.A., Caputo D., Perini M., Salvi F., et al. Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp 2007, 28(12):1430-1438. 10.1002/hbm.20364.
177. Mezzapesa D.M., Ceccarelli A., Dicuonzo F., Carella A., De Caro M.F., Lopez M., et al. Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2007, 28(2):255-259.
178. Agosta F., Valsasina P., Riva N., Copetti M., Messina M.J., Prelle A., et al. The cortical signature of amyotrophic lateral sclerosis. PLoS One 2012, 7(8):e42816. 10.1371/journal.pone.0042816.
179. Cosottini M., Pesaresi I., Piazza S., Diciotti S., Cecchi P., Fabbri S., et al. Structural and functional evaluation of cortical motor areas in amyotrophic lateral sclerosis. Exp Neurol 2012, 234(1):169-180. 10.1016/j.expneurol.2011.12.024.
180. Konrad C., Jansen A., Henningsen H., Sommer J., Turski P.A., Brooks B.R., et al. Subcortical reorganization in amyotrophic lateral sclerosis. Exp Brain Res 2006, 172(3):361-369. 10.1007/s00221-006-0352-7.
181. Stanton B.R., Williams V.C., Leigh P.N., Williams S.C., Blain C.R., Jarosz J.M., et al. Altered cortical activation during a motor task in ALS. Evidence for involvement of central pathways. J Neurol 2007, 254(9):1260-1267. 10.1007/s00415-006-0513-4.
182. Cosottini M., Pesaresi I., Piazza S., Diciotti S., Belmonte G., Battaglini M., et al. Magnetization transfer imaging demonstrates a distributed pattern of microstructural changes of the cerebral cortex in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2011, 32(4):704-708. 10.3174/ajnr.A2356.
183. Ellis C.M., Simmons A., Jones D.K., Bland J., Dawson J.M., Horsfield M.A., et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999, 53(5):1051-1058. 10.1212/WNL.53.5.1051.
184. Toosy A.T., Werring D.J., Orrell R.W., Howard R.S., King M.D., Barker G.J., et al. Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003, 74(9):1250-1257. 10.1136/jnnp.74.9.1250.
185. Cosottini M., Giannelli M., Siciliano G., Lazzarotti G., Michelassi M.C., Del Corona A., et al. Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology 2005, 237(1):258-264. 10.1148/radiol.2371041506.
186. Charil A., Corbo M., Filippi M., Kesavadas C., Agosta F., Munerati E., et al. Structural and metabolic changes in the brain of patients with upper motor neuron disorders: a multiparametric MRI study. Amyotroph Lateral Scler 2009, 10(5-6):269-279. 10.3109/17482960902777339.
187. Graham J.M., Papadakis N., Evans J., Widjaja E., Romanowski C.A., Paley M.N., et al. Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 2004, 63(11):2111-2119. 10.1212/01.WNL.0000145766.03057.E7.
188. Schimrigk S.K., Bellenberg B., Schluter M., Stieltjes B., Drescher R., Rexilius J., et al. Diffusion tensor imaging-based fractional anisotropy quantification in the corticospinal tract of patients with amyotrophic lateral sclerosis using a probabilistic mixture model. AJNR Am J Neuroradiol 2007, 28(4):724-730.
189. Iwata N.K., Aoki S., Okabe S., Arai N., Terao Y., Kwak S., et al. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation. Neurology 2008, 70(7):528-532. 10.1212/01.wnl.0000299186.72374.19.
190. Pierpaoli C., Barnett A., Pajevic S., Chen R., Penix L.R., Virta A., et al. Water diffusion changes in wallerian degeneration and their dependence on white matter architecture. Neuroimage 2001, 13(6 Pt 1):1174-1185. 10.1006/nimg.2001.0765.
191. Beaulieu C., Does M.D., Snyder R.E., Allen P.S. Changes in water diffusion due to wallerian degeneration in peripheral nerve. Magn Reson Med 1996, 36(4):627-631. 10.1002/mrm.1910360419.
192. Wang S., Poptani H., Woo J.H., Desiderio L.M., Elman L.B., McCluskey L.F., et al. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 2006, 239(3):831-838. 10.1148/radiol.2393050573.
193. Mitsumoto H., Ulug A.M., Pullman S.L., Gooch C.L., Chan S., Tang M.X., et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007, 68(17):1402-1410. 10.1212/01.wnl.0000260065.57832.87.
194. Ciccarelli O., Behrens T.E., Altmann D.R., Orrell R.W., Howard R.S., Johansen-Berg H., et al. Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. Brain 2006, 129(Pt 7):1859-1871. 10.1093/brain/awl100.
195. Sage C.A., Peeters R.R., Gorner A., Robberecht W., Sunaert S. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage 2007, 34(2):486-499. 10.1016/j.neuroimage.2006.09.025.
196. Filippini N., Douaud G., Mackay C.E., Knight S., Talbot K., Turner M.R. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 2010, 75(18):1645-1652. 10.1212/WNL.0b013e3181fb84d1.
197. Verstraete E., van den Heuvel M.P., Veldink J.H., Blanken N., Mandl R.C., Hulshoff Pol H.E., et al. Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study. PLoS One 2010, 5(10):e13664. 10.1371/journal.pone.0013664.
198. Li J., Pan P., Song W., Huang R., Chen K., Shang H. A meta-analysis of diffusion tensor imaging studies in amyotrophic lateral sclerosis. Neurobiol Aging 2012, 33(8):1833-1838. 10.1016/j.neurobiolaging.2011.04.007.
199. Cosottini M., Cecchi P., Piazza S., Pesaresi I., Fabbri S., Diciotti S., et al. Mapping cortical degeneration in ALS with magnetization transfer ratio and voxel-based morphometry. PLoS One 2013, 8(7):e68279. 10.1371/journal.pone.0068279.
200. Kassubek J., Unrath A., Huppertz H.J., Lule D., Ethofer T., Sperfeld A.D., et al. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph Lateral Scler Other Motor Neuron Disord 2005, 6(4):213-220. 10.1080/14660820510038538.
201. van der Graaff M.M., Sage C.A., Caan M.W., Akkerman E.M., Lavini C., Majoie C.B., et al. Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study. Brain 2011, 134(Pt 4):1211-1228. 10.1093/brain/awr016.
202. Sage C.A., Van Hecke W., Peeters R., Sijbers J., Robberecht W., Parizel P., et al. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisited. Hum Brain Mapp 2009, 30(11):3657-3675. 10.1002/hbm.20794.
203. Canu E., Agosta F., Riva N., Sala S., Prelle A., Caputo D., et al. The topography of brain microstructural damage in amyotrophic lateral sclerosis assessed using diffusion tensor MR imaging. AJNR Am J Neuroradiol 2011, 32(7):1307-1314. 10.3174/ajnr.A2469.
204. Lillo P., Mioshi E., Burrell J.R., Kiernan M.C., Hodges J.R., Hornberger M. Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One 2012, 7(8):e43993. 10.1371/journal.pone.0043993.
205. Sarro L., Agosta F., Canu E., Riva N., Prelle A., Copetti M., et al. Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: a diffusion tensor tractography study. AJNR Am J Neuroradiol 2011, 32(10):1866-1872. 10.3174/ajnr.A2658.
206. Crespi C., Cerami C., Dodich A., Canessa N., Arpone M., Iannaccone S., et al. Microstructural white matter correlates of emotion recognition impairment in amyotrophic lateral sclerosis. Cortex 2014, 53:1-8. 10.1016/j.cortex.2014.01.002.
207. Agosta F., Rocca M.A., Valsasina P., Sala S., Caputo D., Perini M., et al. A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 2009, 80(1):53-55. 10.1136/jnnp.2008.154252.
208. Valsasina P., Agosta F., Benedetti B., Caputo D., Perini M., Salvi F., et al. Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007, 78(5):480-484. 10.1136/jnnp.2006.100032.
209. Wang Y., Liu L., Ma L., Huang X., Lou X., Wang Y., et al. Preliminary study on cervical spinal cord in patients with amyotrophic lateral sclerosis using MR diffusion tensor imaging. Acad Radiol 2014, 21(5):590-596. 10.1016/j.acra.2014.01.014.
210. Sach M., Winkler G., Glauche V., Liepert J., Heimbach B., Koch M.A., et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004, 127(Pt 2):340-350. 10.1093/brain/awh041.
211. Ng M.C., Ho J.T., Ho S.L., Lee R., Li G., Cheng T.S., et al. Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation. J Magn Reson Imaging 2008, 27(1):8-13. 10.1002/jmri.21217.
212. Iwata N.K., Kwan J.Y., Danielian L.E., Butman J.A., Tovar-Moll F., Bayat E., et al. White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 2011, 134(Pt 9):2642-2655. 10.1093/brain/awr178.
213. Filippi M., van den Heuvel M.P., Fornito A., He Y., Hulshoff Pol H.E., Agosta F., et al. Assessment of system dysfunction in the brain through MRI-based connectomics. Lancet Neurol 2013, 12(12):1189-1199. 10.1016/S1474-4422(13)70144-3.
214. Agosta F., Galantucci S., Riva N., Chio A., Messina S., Iannaccone S., et al. Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS. Hum Brain Mapp 2014, 35(4):1710-1722. 10.1002/hbm.22286.
215. Blain C.R., Williams V.C., Johnston C., Stanton B.R., Ganesalingam J., Jarosz J.M., et al. A longitudinal study of diffusion tensor MRI in ALS. Amyotroph Lateral Scler 2007, 8(6):348-355. 10.1080/17482960701548139.
216. Menke R.A., Abraham I., Thiel C.S., Filippini N., Knight S., Talbot K., et al. Fractional anisotropy in the posterior limb of the internal capsule and prognosis in amyotrophic lateral sclerosis. Arch Neurol 2012, 69(11):1493-1499. 10.1001/archneurol.2012.1122.
217. Agosta F., Pagani E., Petrolini M., Sormani M.P., Caputo D., Perini M., et al. MRI predictors of long-term evolution in amyotrophic lateral sclerosis. Eur J Neurosci 2010, 32(9):1490-1496. 10.1111/j.1460-9568.2010.07445.x.
218. Keil C., Prell T., Peschel T., Hartung V., Dengler R., Grosskreutz J. Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci 2012, 13:141. 10.1186/1471-2202-13-141.
219. Verstraete E., Veldink J.H., Mandl R.C., van den Berg L.H., van den Heuvel M.P. Impaired structural motor connectome in amyotrophic lateral sclerosis. PLoS One 2011, 6(9):e24239. 10.1371/journal.pone.0024239.
220. Verstraete E., Veldink J.H., van den Berg L.H., van den Heuvel M.P. Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis. Hum Brain Mapp 2014, 35(4):1351-1361. 10.1002/hbm.22258.
221. Foerster B.R., Dwamena B.A., Petrou M., Carlos R.C., Callaghan B.C., Pomper M.G. Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis. Acad Radiol 2012, 19(9):1075-1086. 10.1016/j.acra.2012.04.012.
222. Chio A., Calvo A., Moglia C., Mazzini L., Mora G., group PARALS study Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011, 82(7):740-746. 10.1136/jnnp.2010.235952.
223. Prell T., Peschel T., Hartung V., Kaufmann J., Klauschies R., Bodammer N., et al. Diffusion tensor imaging patterns differ in bulbar and limb onset amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2013, 115(8):1281-1287. 10.1016/j.clineuro.2012.11.031.
224. Takahashi T., Katada S., Onodera O. Polyglutamine diseases: where does toxicity come from? What is toxicity? Where are we going?. J Mol Cell Biol 2010, 2(4):180-191. 10.1093/jmcb/mjq005.
225. Bohanna I., Georgiou-Karistianis N., Hannan A.J., Egan G.F. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res Rev 2008, 58(1):209-225. 10.1016/j.brainresrev.2008.04.001.
226. Kloppel S., Chu C., Tan G.C., Draganski B., Johnson H., Paulsen J.S., et al. Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease. Neurology 2009, 72(5):426-431. 10.1212/01.wnl.0000341768.28646.b6.
227. Tabrizi S.J., Langbehn D.R., Leavitt B.R., Roos R.A., Durr A., Craufurd D., et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009, 8(9):791-801. 10.1016/S1474-4422(09)70170-X.
228. Kloppel S., Draganski B., Golding C.V., Chu C., Nagy Z., Cook P.A., et al. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 2008, 131(Pt 1):196-204. 10.1093/brain/awm275.
229. Reading S.A., Yassa M.A., Bakker A., Dziorny A.C., Gourley L.M., Yallapragada V., et al. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study. Psychiatry Res 2005, 140(1):55-62. 10.1016/j.pscychresns.2005.05.011.
230. Rosas H.D., Tuch D.S., Hevelone N.D., Zaleta A.K., Vangel M., Hersch S.M., et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures. Mov Disord 2006, 21(9):1317-1325. 10.1002/mds.20979.
231. Dumas E.M., van den Bogaard S.J., Ruber M.E., Reilman R.R., Stout J.C., Craufurd D., et al. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Hum Brain Mapp 2012, 33(1):203-212. 10.1002/hbm.21205.
232. Mandelli M.L., Savoiardo M., Minati L., Mariotti C., Aquino D., Erbetta A., et al. Decreased diffusivity in the caudate nucleus of presymptomatic Huntington disease gene carriers: which explanation?. AJNR Am J Neuroradiol 2010, 31(4):706-710. 10.3174/ajnr.A1891.
233. Rizk-Jackson A., Stoffers D., Sheldon S., Kuperman J., Dale A., Goldstein J., et al. Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques. Neuroimage 2011, 56(2):788-796. 10.1016/j.neuroimage.2010.04.273.
234. Rosas H.D., Lee S.Y., Bender A.C., Zaleta A.K., Vangel M., Yu P., et al. Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection". Neuroimage 2010, 49(4):2995-3004. 10.1016/j.neuroimage.2009.10.015.
235. Stoffers D., Sheldon S., Kuperman J.M., Goldstein J., Corey-Bloom J., Aron A.R. Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology 2010, 74(15):1208-1216. 10.1212/WNL.0b013e3181d8c20a.
236. Di Paola M., Luders E., Cherubini A., Sanchez-Castaneda C., Thompson P.M., Toga A.W., et al. Multimodal MRI analysis of the corpus callosum reveals white matter differences in presymptomatic and early Huntington's disease. Cereb Cortex 2012, 22(12):2858-2866. 10.1093/cercor/bhr360.
237. Sanchez-Castaneda C., Cherubini A., Elifani F., Peran P., Orobello S., Capelli G., et al. Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging. Hum Brain Mapp 2013, 34(7):1625-1635. 10.1002/hbm.22019.
238. Dominguez D.J., Egan G.F., Gray M.A., Poudel G.R., Churchyard A., Chua P., et al. Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study. PLoS One 2013, 8(9):e74131. 10.1371/journal.pone.0074131.
239. Novak M.J., Seunarine K.K., Gibbard C.R., Hobbs N.Z., Scahill R.I., Clark C.A., et al. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression. Cortex 2014, 52:98-112. 10.1016/j.cortex.2013.11.009.
240. Douaud G., Behrens T.E., Poupon C., Cointepas Y., Jbabdi S., Gaura V., et al. In vivo evidence for the selective subcortical degeneration in Huntington's disease. Neuroimage 2009, 46(4):958-966. 10.1016/j.neuroimage.2009.03.044.
241. Mascalchi M., Lolli F., Della Nave R., Tessa C., Petralli R., Gavazzi C., et al. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 2004, 232(3):867-873. 10.1148/radiol.2322030820.
242. Seppi K., Schocke M.F., Mair K.J., Esterhammer R., Weirich-Schwaiger H., Utermann B., et al. Diffusion-weighted imaging in Huntington's disease. Mov Disord 2006, 21(7):1043-1047. 10.1002/mds.20868.
243. Della Nave R., Ginestroni A., Tessa C., Giannelli M., Piacentini S., Filippi M., et al. Regional distribution and clinical correlates of white matter structural damage in Huntington disease: a tract-based spatial statistics study. AJNR Am J Neuroradiol 2010, 31(9):1675-1681. 10.3174/ajnr.A2128.
244. Rees E.M., Farmer R., Cole J.H., Haider S., Durr A., Landwehrmeyer B., et al. Cerebellar abnormalities in Huntington's disease: a role in motor and psychiatric impairment?. Mov Disord 2014, 29(13):1648-1654. 10.1002/mds.25984.
245. Phillips O., Squitieri F., Sanchez-Castaneda C., Elifani F., Griguoli A., Maglione V., et al. The corticospinal tract in Huntington's disease. Cereb Cortex 2014, 10.1093/cercor/bhu065.
246. Georgiou-Karistianis N., Gray M.A., Dominguez D.J., Dymowski A.R., Bohanna I., Johnston L.A., et al. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study. Neurobiol Dis 2013, 51:82-92. 10.1016/j.nbd.2012.10.001.
247. Poudel G.R., Stout J.C., Dominguez D.J., Salmon L., Churchyard A., Chua P., et al. White matter connectivity reflects clinical and cognitive status in Huntington's disease. Neurobiol Dis 2014, 65:180-187. 10.1016/j.nbd.2014.01.013.
248. Blockx I., Verhoye M., Van Audekerke J., Bergwerf I., Kane J.X., Delgado Y.P.R., et al. Identification and characterization of Huntington related pathology: an in vivo DKI imaging study. Neuroimage 2012, 63(2):653-662. 10.1016/j.neuroimage.2012.06.032.
249. Weaver K.E., Richards T.L., Liang O., Laurino M.Y., Samii A., Aylward E.H. Longitudinal diffusion tensor imaging in Huntington's disease. Exp Neurol 2009, 216(2):525-529. 10.1016/j.expneurol.2008.12.026.
250. Sritharan A., Egan G.F., Johnston L., Horne M., Bradshaw J.L., Bohanna I., et al. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease. J Neurol Neurosurg Psychiatry 2010, 81(3):257-262. 10.1136/jnnp.2007.142786.
251. Vandenberghe W., Demaerel P., Dom R., Maes F. Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease. J Neurol 2009, 256(1):109-114. 10.1007/s00415-009-0086-0.
252. Rosas H.D., Doros G., Gevorkian S., Malarick K., Reuter M., Coutu J.P., et al. PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease. Neurology 2014, 82(10):850-857. 10.1212/WNL.0000000000000187.
253. Mascalchi M., Vella A. Magnetic resonance and nuclear medicine imaging in ataxias. Handb Clin Neurol 2012, 103:85-110. 10.1016/B978-0-444-51892-7.00004-8.
254. Mascalchi M., Filippi M., Floris R., Fonda C., Gasparotti R., Villari N. Diffusion-weighted MR of the brain: methodology and clinical application. Radiol Med 2005, 109(3):155-197.
255. Della Nave R., Foresti S., Tessa C., Moretti M., Ginestroni A., Gavazzi C., et al. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias. Neuroimage 2004, 22(2):698-705. 10.1016/j.neuroimage.2004.01.035.
256. Mandelli M.L., De Simone T., Minati L., Bruzzone M.G., Mariotti C., Fancellu R., et al. Diffusion tensor imaging of spinocerebellar ataxias types 1 and 2. AJNR Am J Neuroradiol 2007, 28(10):1996-2000. 10.3174/ajnr.A0716.
257. Pellecchia M.T., Barone P., Mollica C., Salvatore E., Ianniciello M., Longo K., et al. Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord 2009, 24(5):689-696. 10.1002/mds.22440.
258. Pellecchia M.T., Barone P., Vicidomini C., Mollica C., Salvatore E., Ianniciello M., et al. Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. Mov Disord 2011, 26(7):1303-1309. 10.1002/mds.23601.
259. Rizzo G., Tonon C., Valentino M.L., Manners D., Fortuna F., Gellera C., et al. Brain diffusion-weighted imaging in Friedreich's ataxia. Mov Disord 2011, 26(4):705-712. 10.1002/mds.23518.
260. Della Nave R., Ginestroni A., Tessa C., Salvatore E., De Grandis D., Plasmati R., et al. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics. Neuroimage 2008, 43(1):10-19. 10.1016/j.neuroimage.2008.06.036.
261. Della Nave R., Ginestroni A., Giannelli M., Tessa C., Salvatore E., Salvi F., et al. Brain structural damage in Friedreich's ataxia. J Neurol Neurosurg Psychiatry 2008, 79(1):82-85. 10.1136/jnnp.2007.124297.
262. Pagani E., Ginestroni A., Della Nave R., Agosta F., Salvi F., De Michele G., et al. Assessment of brain white matter fiber bundle atrophy in patients with Friedreich ataxia. Radiology 2010, 255(3):882-889. 10.1148/radiol.10091742.
263. Alcauter S., Barrios F.A., Diaz R., Fernandez-Ruiz J. Gray and white matter alterations in spinocerebellar ataxia type 7: an in vivo DTI and VBM study. Neuroimage 2011, 55(1):1-7. 10.1016/j.neuroimage.2010.12.014.
264. Sahama I., Sinclair K., Fiori S., Pannek K., Lavin M., Rose S. Altered corticomotor-cerebellar integrity in young ataxia telangiectasia patients. Mov Disord 2014, 29(10):1289-1298. 10.1002/mds.25970.
265. Mascalchi M., Toschi N., Giannelli M., Ginestroni A., Della Nave R., Nicolai E., et al. Progression of microstructural damage in spinocerebellar ataxia type 2. A longitudinal diffusion tensor study. AJNR Am J Neuroradiol 2015, 10.3174/ajnr.A4343.
266. Prakash N., Hageman N., Hua X., Toga A.W., Perlman S.L., Salamon N. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes. Neuroimage 2009, 47(Suppl. 2):T72-T81. 10.1016/j.neuroimage.2009.05.013.
267. Taoka T., Kin T., Nakagawa H., Hirano M., Sakamoto M., Wada T., et al. Diffusivity and diffusion anisotropy of cerebellar peduncles in cases of spinocerebellar degenerative disease. Neuroimage 2007, 37(2):387-393. 10.1016/j.neuroimage.2007.05.028.
268. Koeppen A.H. Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci 2011, 303(1-2):1-12. 10.1016/j.jns.2011.01.010.
269. Zalesky A., Akhlaghi H., Corben L.A., Bradshaw J.L., Delatycki M.B., Storey E., et al. Cerebello-cerebral connectivity deficits in Friedreich ataxia. Brain Struct Funct 2013, 10.1007/s00429-013-0547-1.
270. Clemm von Hohenberg C., Schocke M.F., Wigand M.C., Nachbauer W., Guttmann C.R., Kubicki M., et al. Radial diffusivity in the cerebellar peduncles correlates with clinical severity in Friedreich ataxia. Neurol Sci 2013, 34(8):1459-1462. 10.1007/s10072-013-1402-0.
271. Akhlaghi H., Yu J., Corben L., Georgiou-Karistianis N., Bradshaw J.L., Storey E., et al. Cognitive deficits in Friedreich ataxia correlate with micro-structural changes in dentatorubral tract. Cerebellum 2014, 13(2):187-198. 10.1007/s12311-013-0525-4.
272. Della Nave R., Ginestroni A., Diciotti S., Salvatore E., Soricelli A., Mascalchi M. Axial diffusivity is increased in the degenerating superior cerebellar peduncles of Friedreich's ataxia. Neuroradiology 2011, 53(5):367-372. 10.1007/s00234-010-0807-1.
273. Salat D.H., Tuch D.S., van der Kouwe A.J., Greve D.N., Pappu V., Lee S.Y., et al. White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging 2010, 31(2):244-256. 10.1016/j.neurobiolaging.2008.03.013.
274. Lowe J., Lennox G., Leigh P.N. Disorders of movement and system degeneration. Greenfield's neuropatology 1997, 281-366. Arnold, London, England. D.L. Graham, P.L. Lantos (Eds.).
275. Firat A.K., Karakas H.M., Firat Y., Yakinci C. Quantitative evaluation of brain involvement in ataxia telangiectasia by diffusion weighted MR imaging. Eur J Radiol 2005, 56(2):192-196. 10.1016/j.ejrad.2005.04.009.
276. Seidel K., Siswanto S., Brunt E.R., den Dunnen W., Korf H.W., Rub U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol 2012, 124(1):1-21. 10.1007/s00401-012-1000-x.
277. Reginold W., Lang A.E., Marras C., Heyn C., Alharbi M., Mikulis D.J. Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy. Parkinsonism Relat Disord 2014, 20(2):222-225. 10.1016/j.parkreldis.2013.10.002.
278. Guimaraes R.P., D'Abreu A., Yasuda C.L., Franca M.C., Silva B.H., Cappabianco F.A., et al. A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3. Mov Disord 2013, 28(8):1125-1132. 10.1002/mds.25451.
279. Lu C.F., Soong B.W., Wu H.M., Teng S., Wang P.S., Wu Y.T. Disrupted cerebellar connectivity reduces whole-brain network efficiency in multiple system atrophy. Mov Disord 2013, 28(3):362-369. 10.1002/mds.25314.
280. Kang J.S., Klein J.C., Baudrexel S., Deichmann R., Nolte D., Hilker R. White matter damage is related to ataxia severity in SCA3. J Neurol 2014, 261(2):291-299. 10.1007/s00415-013-7186-6.
281. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003, 4(6):469-480. 10.1038/nrn1119.
282. Le Bihan D., Johansen-Berg H. Diffusion MRI at 25: exploring brain tissue structure and function. Neuroimage 2012, 61(2):324-341. 10.1016/j.neuroimage.2011.11.006.
283. Sporns O. Discovering the human connectome 2012, MIT press.
284. Assaf Y., Alexander D.C., Jones D.K., Bizzi A., Behrens T.E., Clark C.A., et al. The CONNECT project: combining macro- and micro-structure. Neuroimage 2013, 80:273-282. 10.1016/j.neuroimage.2013.05.055.
285. Van Essen D.C., Ugurbil K., Auerbach E., Barch D., Behrens T.E., Bucholz R., et al. The Human Connectome Project: a data acquisition perspective. Neuroimage 2012, 62(4):2222-2231. 10.1016/j.neuroimage.2012.02.018.
286. Van Essen D.C., Smith S.M., Barch D.M., Behrens T.E., Yacoub E., Ugurbil K., et al. The WU-Minn Human Connectome Project: an overview. Neuroimage 2013, 80:62-79. 10.1016/j.neuroimage.2013.05.041.
287. Van Essen D.C., Ugurbil K. The future of the human connectome. Neuroimage 2012, 62(2):1299-1310. 10.1016/j.neuroimage.2012.01.032.
288. Jbabdi S., Sotiropoulos S.N., Savio A.M., Grana M., Behrens T.E. Model-based analysis of multishell diffusion MR data for tractography: how to get over fitting problems. Magn Reson Med 2012, 68(6):1846-1855. 10.1002/mrm.24204.
289. Setsompop K., Kimmlingen R., Eberlein E., Witzel T., Cohen-Adad J., McNab J.A., et al. Pushing the limits of in vivo diffusion MRI for the Human Connectome Project. Neuroimage 2013, 80:220-233. 10.1016/j.neuroimage.2013.05.078.
290. Sotiropoulos S.N., Jbabdi S., Andersson J.L., Woolrich M.W., Ugurbil K., Behrens T.E. RubiX: combining spatial resolutions for Bayesian inference of crossing fibers in diffusion MRI. IEEE Trans Med Imaging 2013, 32(6):969-982. 10.1109/TMI.2012.2231873.
291. Sotiropoulos S.N., Jbabdi S., Xu J., Andersson J.L., Moeller S., Auerbach E.J., et al. Advances in diffusion MRI acquisition and processing in the Human Connectome Project. Neuroimage 2013, 80:125-143. 10.1016/j.neuroimage.2013.05.057.
292. Sotiropoulos S.N., Moeller S., Jbabdi S., Xu J., Andersson J.L., Auerbach E.J., et al. Effects of image reconstruction on fiber orientation mapping from multichannel diffusion MRI: reducing the noise floor using SENSE. Magn Reson Med 2013, 70(6):1682-1689. 10.1002/mrm.24623.
293. Ugurbil K., Xu J., Auerbach E.J., Moeller S., Vu A.T., Duarte-Carvajalino J.M., et al. Pushing spatial and temporal resolution for functional and diffusion MRI in the Human Connectome Project. Neuroimage 2013, 80:80-104. 10.1016/j.neuroimage.2013.05.012.
294. Le Bihan D., Mangin J.F., Poupon C., Clark C.A., Pappata S., Molko N., et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001, 13(4):534-546. 10.1002/jmri.1076.
295. Ennis D.B., Kindlmann G. Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images. Magn Reson Med 2006, 55(1):136-146. 10.1002/mrm.20741.
296. Jones D.K., Knosche T.R., Turner R. White matter integrity, fiber count, and other fallacies: the do's and don'ts of diffusion MRI. Neuroimage 2013, 73:239-254. 10.1016/j.neuroimage.2012.06.081.
297. Wheeler-Kingshott C.A., Cercignani M. About "axial" and "radial" diffusivities. Magn Reson Med 2009, 61(5):1255-1260. 10.1002/mrm.21965.
298. Kindlmann G., Ennis D.B., Whitaker R.T., Westin C.F. Diffusion tensor analysis with invariant gradients and rotation tangents. IEEE Trans Med Imaging 2007, 26(11):1483-1499. 10.1109/TMI.2007.907277.
299. Le Bihan D. The 'wet mind': water and functional neuroimaging. Phys Med Biol 2007, 52(7):R57-R90. 10.1088/0031-9155/52/7/R02.
300. Assaf Y., Basser P.J. Composite hindered and restricted model of diffusion (CHARMED) MR imaging of the human brain. Neuroimage 2005, 27(1):48-58. 10.1016/j.neuroimage.2005.03.042.
301. Assaf Y., Blumenfeld-Katzir T., Yovel Y., Basser P.J. AxCaliber: a method for measuring axon diameter distribution from diffusion MRI. Magn Reson Med 2008, 59(6):1347-1354. 10.1002/mrm.21577.
302. Zhang H., Hubbard P.L., Parker G.J., Alexander D.C. Axon diameter mapping in the presence of orientation dispersion with diffusion MRI. Neuroimage 2011, 56(3):1301-1315. 10.1016/j.neuroimage.2011.01.084.
303. Assaf Y., Cohen Y. Assignment of the water slow-diffusing component in the central nervous system using q-space diffusion MRS: implications for fiber tract imaging. Magn Reson Med 2000, 43(2):191-199. 10.1002/mrm.10022.
304. Tuch D.S. Q-ball imaging. Magn Reson Med 2004, 52(6):1358-1372. 10.1002/mrm.20279.
305. Tuch D.S., Reese T.G., Wiegell M.R., Wedeen V.J. Diffusion MRI of complex neural architecture. Neuron 2003, 40(5):885-895. 10.1016/S0896-6273(03)00758-X.
306. Heidemann R.M., Porter D.A., Anwander A., Feiweier T., Heberlein K., Knosche T.R., et al. Diffusion imaging in humans at 7T using readout-segmented EPI and GRAPPA. Magn Reson Med 2010, 64(1):9-14. 10.1002/mrm.22480.
307. Feinberg D.A., Moeller S., Smith S.M., Auerbach E., Ramanna S., Gunther M., et al. Multiplexed echo planar imaging for sub-second whole brain FMRI and fast diffusion imaging. PLoS One 2010, 5(12):e15710. 10.1371/journal.pone.0015710.
308. Menzel M.I., Tan E.T., Khare K., Sperl J.I., King K.F., Tao X., et al. Accelerated diffusion spectrum imaging in the human brain using compressed sensing. Magn Reson Med 2011, 66(5):1226-1233. 10.1002/mrm.23064.
309. Michailovich O., Rathi Y., Dolui S. Spatially regularized compressed sensing for high angular resolution diffusion imaging. IEEE Trans Med Imaging 2011, 30(5):1100-1115. 10.1109/TMI.2011.2142189.
310. Shemesh N., Barazany D., Sadan O., Bar L., Zur Y., Barhum Y., et al. Mapping apparent eccentricity and residual ensemble anisotropy in the gray matter using angular double-pulsed-field-gradient MRI. Magn Reson Med 2012, 68(3):794-806. 10.1002/mrm.23300.
311. Shemesh N., Ozarslan E., Bar-Shir A., Basser P.J., Cohen Y. Observation of restricted diffusion in the presence of a free diffusion compartment: single- and double-PFG experiments. J Magn Reson 2009, 200(2):214-225. 10.1016/j.jmr.2009.07.005.
312. Hansen M.B., Jespersen S.N., Leigland L.A., Kroenke C.D. Using diffusion anisotropy to characterize neuronal morphology in gray matter: the orientation distribution of axons and dendrites in the NeuroMorpho.org database. Front Integr Neurosci 2013, 7:31. 10.3389/fnint.2013.00031.
313. Zhang H., Schneider T., Wheeler-Kingshott C.A., Alexander D.C. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 2012, 61(4):1000-1016. 10.1016/j.neuroimage.2012.03.072.
314. Bullmore E., Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 2009, 10(3):186-198. 10.1038/nrn2575.
315. Matthews P.M., Honey G.D., Bullmore E.T. Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci 2006, 7(9):732-744. 10.1038/nrn1929.
316. van den Heuvel M.P., Hulshoff Pol H.E. Exploring the brain network: a review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol 2010, 20(8):519-534. 10.1016/j.euroneuro.2010.03.008.
317. Mascalchi M., Ginestroni A., Toschi N., Poggesi A., Cecchi P., Salvadori E., et al. The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study. Hum Brain Mapp 2012, 10.1002/hbm.22216.
318. Tessa C., Lucetti C., Diciotti S., Baldacci F., Paoli L., Cecchi P., et al. Decreased and increased cortical activation coexist in de novo Parkinson's disease. Exp Neurol 2010, 224(1):299-306. 10.1016/j.expneurol.2010.04.005.
319. Ginestroni A., Diciotti S., Cecchi P., Pesaresi I., Tessa C., Giannelli M., et al. Neurodegeneration in Friedreich's ataxia is associated with a mixed activation pattern of the brain. A fMRI study. Hum Brain Mapp 2012, 33(8):1780-1791. 10.1002/hbm.21319.
320. Passamonti L., Salsone M., Toschi N., Cerasa A., Giannelli M., Chiriaco C., et al. Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease. Brain Behav 2013, 3(3):249-262. 10.1002/brb3.115.
321. Jezzard P.J., Matthews P.M., Smith S.M. Functional MRI: an introduction to methods 2002, Oxford university press.
322. Lee M.H., Smyser C.D., Shimony J.S. Resting-state fMRI: a review of methods and clinical applications. AJNR Am J Neuroradiol 2013, 34(10):1866-1872. 10.3174/ajnr.A3263.
323. Ashburner J., Friston K.J. Morphometry. Human brain function 2003, 707-724. Academic Press. F.K. Frackowiak RSJ, C. Frith, R. Dolan, K.J. Friston, C.J. Price, S. Zeki, J. Ashburner, W.D. Penny (Eds.).
324. Chung M.K., Worsley K.J., Robbins S., Paus T., Taylor J., Giedd J.N., et al. Deformation-based surface morphometry applied to gray matter deformation. Neuroimage 2003, 18(2):198-213. 10.1016/S1053-8119(02)00017-4.
325. Good C.D., Ashburner J., Frackowiak R.S. Computational neuroanatomy: new perspectives for neuroradiology. Rev Neurol (Paris) 2001, 157(8-9 Pt 1):797-806.
326. Hua X., Leow A.D., Parikshak N., Lee S., Chiang M.C., Toga A.W., et al. Alzheimer's Disease Neuroimaging I. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage 2008, 43(3):458-469. 10.1016/j.neuroimage.2008.07.013.
327. Pereira J.B., Ibarretxe-Bilbao N., Marti M.J., Compta Y., Junque C., Bargallo N., et al. Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp 2012, 33(11):2521-2534. 10.1002/hbm.21378.
328. Takao H., Abe O., Ohtomo K. Computational analysis of cerebral cortex. Neuroradiology 2010, 52(8):691-698. 10.1007/s00234-010-0715-4.
329. Della Nave R., Ginestroni A., Tessa C., Cosottini M., Giannelli M., Salvatore E., et al. Brain structural damage in spinocerebellar ataxia type 2. A voxel-based morphometry study. Mov Disord 2008, 23(6):899-903. 10.1002/mds.21982.
330. Constantinescu R., Mondello S. Cerebrospinal fluid biomarker candidates for parkinsonian disorders. Front Neurol 2012, 3:187. 10.3389/fneur.2012.00187.
331. Kroksveen A.C., Opsahl J.A., Aye T.T., Ulvik R.J., Berven F.S. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics. J Proteomics 2011, 74(4):371-388. 10.1016/j.jprot.2010.11.010.
332. Zhang A.H., Sun H., Wang X.J. Recent advances in metabolomics in neurological disease, and future perspectives. Anal Bioanal Chem 2013, 405(25):8143-8150. 10.1007/s00216-013-7061-4.
333. Zhang J., Goodlett D.R., Montine T.J. Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases. J Alzheimers Dis 2005, 8(4):377-386.
334. Witten I.H., Frank E. Data mining: practical machine learning tools and techniques 2005, Elsevier Science. 2nd ed.
335. Orru G., Pettersson-Yeo W., Marquand A.F., Sartori G., Mechelli A. Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev 2012, 36(4):1140-1152. 10.1016/j.neubiorev.2012.01.004.
336. Mwangi B., Tian T.S., Soares J.C. A review of feature reduction techniques in neuroimaging. Neuroinformatics 2013, 10.1007/s12021-013-9204-3.
337. Diciotti S., Ginestroni A., Bessi V., Giannelli M., Tessa C., Bracco L., et al. Identification of mild Alzheimer's disease through automated classification of structural MRI features. Conf Proc IEEE Eng Med Biol Soc 2012, 2012:428-431. 10.1109/EMBC.2012.6345959.
338. Cosottini M., Giannelli M., Vannozzi F., Pesaresi I., Piazza S., Belmonte G., et al. Evaluation of corticospinal tract impairment in the brain of patients with amyotrophic lateral sclerosis by using diffusion tensor imaging acquisition schemes with different numbers of diffusion-weighting directions. J Comput Assist Tomogr 2010, 34(5):746-750. 10.1097/RCT.0b013e3181e35129.
339. Giannelli M., Cosottini M., Michelassi M.C., Lazzarotti G., Belmonte G., Bartolozzi C., et al. Dependence of brain DTI maps of fractional anisotropy and mean diffusivity on the number of diffusion weighting directions. J Appl Clin Med Phys 2010, 11(1):2927. 10.1120/jacmp.v11i1.2927.
340. Jones D.K., Cercignani M. Twenty-five pitfalls in the analysis of diffusion MRI data. NMR Biomed 2010, 23(7):803-820. 10.1002/nbm.1543.
341. Koay C.G., Carew J.D., Alexander A.L., Basser P.J., Meyerand M.E. Investigation of anomalous estimates of tensor-derived quantities in diffusion tensor imaging. Magn Reson Med 2006, 55(4):930-936. 10.1002/mrm.20832.
342. Koay C.G., Chang L.C., Carew J.D., Pierpaoli C., Basser P.J. A unifying theoretical and algorithmic framework for least squares methods of estimation in diffusion tensor imaging. J Magn Reson 2006, 182(1):115-125. 10.1016/j.jmr.2006.06.020.
343. Alexander A.L., Lee J.E., Wu Y.C., Field A.S. Comparison of diffusion tensor imaging measurements at 3.0 T versus 1.5 T with and without parallel imaging. Neuroimaging Clin N Am 2006, 16(2):299-309. 10.1016/j.nic.2006.02.006.
344. Padhani A.R., Liu G., Koh D.M., Chenevert T.L., Thoeny H.C., Takahara T., et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009, 11(2):102-125. 10.1593/neo.81328.
345. Dalaker T.O., Larsen J.P., Bergsland N., Beyer M.K., Alves G., Dwyer M.G., et al. Brain atrophy and white matter hyperintensities in early Parkinson's disease(a). Mov Disord 2009, 24(15):2233-2241. 10.1002/mds.22754.
346. Nopoulos P.C., Aylward E.H., Ross C.A., Johnson H.J., Magnotta V.A., Juhl A.R., et al. Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis 2010, 40(3):544-554. 10.1016/j.nbd.2010.07.014.
347. Soneson C., Fontes M., Zhou Y., Denisov V., Paulsen J.S., Kirik D., et al. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol Dis 2010, 40(3):531-543. 10.1016/j.nbd.2010.07.013.
348. Spulber G., Simmons A., Muehlboeck J.S., Mecocci P., Vellas B., Tsolaki M., et al. An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment. J Intern Med 2013, 273(4):396-409. 10.1111/joim.12028.
349. Weiner M.W., Veitch D.P., Aisen P.S., Beckett L.A., Cairns N.J., Green R.C., et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement 2012, 8(1 Suppl.):S1-S68. 10.1016/j.jalz.2011.09.172.
350. Sasaki M., Yamada K., Watanabe Y., Matsui M., Ida M., Fujiwara S., et al. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 2008, 249(2):624-630. 10.1148/radiol.2492071681.
351. Pagani E., Hirsch J.G., Pouwels P.J., Horsfield M.A., Perego E., Gass A., et al. Intercenter differences in diffusion tensor MRI acquisition. J Magn Reson Imaging 2010, 31(6):1458-1468. 10.1002/jmri.22186.
352. Vollmar C., O'Muircheartaigh J., Barker G.J., Symms M.R., Thompson P., Kumari V., et al. Identical, but not the same: Intra-site and inter-site reproducibility of fractional anisotropy measures on two 3.0 T scanners. NeuroImage 2010, 51(4):1384-1394. 10.1016/j.neuroimage.2010.03.046.
353. Teipel S.J., Reuter S., Stieltjes B., Acosta-Cabronero J., Ernemann U., Fellgiebel A., et al. Multicenter stability of diffusion tensor imaging measures: a European clinical and physical phantom study. Psychiatry Res 2011, 194(3):363-371. 10.1016/j.pscychresns.2011.05.012.
354. Zhu T., Hu R., Qiu X., Taylor M., Tso Y., Yiannoutsos C., et al. Quantification of accuracy and precision of multi-center DTI measurements: a diffusion phantom and human brain study. Neuroimage 2011, 56(3):1398-1411. 10.1016/j.neuroimage.2011.02.010.
355. Fox R.J., Sakaie K., Lee J.C., Debbins J.P., Liu Y., Arnold D.L., et al. A validation study of multicenter diffusion tensor imaging: reliability of fractional anisotropy and diffusivity values. AJNR Am J Neuroradiol 2012, 33(4):695-700. 10.3174/ajnr.A2844.
356. Magnotta V.A., Matsui J.T., Liu D., Johnson H.J., Long J.D., Bolster B.D., et al. Multicenter reliability of diffusion tensor imaging. Brain Connect 2012, 2(6):345-355. 10.1089/brain.2012.0112.
357. Huang L., Wang X., Baliki M.N., Wang L., Apkarian A.V., Parrish T.B. Reproducibility of structural, resting-state BOLD and DTI data between identical scanners. PLoS One 2012, 7(10):e47684. 10.1371/journal.pone.0047684.
358. Farrell J.A., Landman B.A., Jones C.K., Smith S.A., Prince J.L., van Zijl P.C., et al. Effects of signal-to-noise ratio on the accuracy and reproducibility of diffusion tensor imaging-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5 T. J Magn Reson Imaging 2007, 26(3):756-767. 10.1002/jmri.21053.
359. Giannelli M., Belmonte G., Toschi N., Pesaresi I., Ghedin P., Traino A.C., et al. Technical note: DTI measurements of fractional anisotropy and mean diffusivity at 1.5 T: comparison of two radiofrequency head coils with different functional designs and sensitivities. Med Phys 2011, 38(6):3205-3211. 10.1118/1.3592013.
360. Landman B.A., Farrell J.A., Huang H., Prince J.L., Mori S. Diffusion tensor imaging at low SNR: nonmonotonic behaviors of tensor contrasts. Magn Reson Imaging 2008, 26(6):790-800. 10.1016/j.mri.2008.01.034.
361. Jones D.K., Basser P.J. "Squashing peanuts and smashing pumpkins": how noise distorts diffusion-weighted MR data. Magn Reson Med 2004, 52(5):979-993. 10.1002/Mrm.20283.
362. Jones D.K. Precision and accuracy in diffusion tensor magnetic resonance imaging. Top Magn Reson Imaging 2010, 21(2):87-99. 10.1097/RMR.0b013e31821e56ac.
363. Schmithorst V.J., Dardzinski B.J. Automatic gradient preemphasis adjustment: a 15-minute journey to improved diffusion-weighted echo-planar imaging. Magn Reson Med 2002, 47(1):208-212. 10.1002/mrm.10022.
364. Bammer R., Markl M., Barnett A., Acar B., Alley M.T., Pelc N.J., et al. Analysis and generalized correction of the effect of spatial gradient field distortions in diffusion-weighted imaging. Magn Reson Med 2003, 50(3):560-569. 10.1002/mrm.10545.
365. Delakis I., Moore E.M., Leach M.O., De Wilde J.P. Developing a quality control protocol for diffusion imaging on a clinical MRI system. Phys Med Biol 2004, 49(8):1409-1422. 10.1088/0031-9155/49/8/003.
366. Nagy Z., Weiskopf N., Alexander D.C., Deichmann R. A method for improving the performance of gradient systems for diffusion-weighted MRI. Magn Reson Med 2007, 58(4):763-768. 10.1002/mrm.21379.
367. Wu Y.C., Alexander A.L. A method for calibrating diffusion gradients in diffusion tensor imaging. J Comput Assist Tomogr 2007, 31(6):984-993. 10.1097/rct.0b013e31805152fa.
368. Chenevert T.L., Galban C.J., Ivancevic M.K., Rohrer S.E., Londy F.J., Kwee T.C., et al. Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies. J Magn Reson Imaging 2011, 34(4):983-987. 10.1002/Jmri.22363.
369. Wang Z.Y.J., Seo Y., Chia J.M., Rollins N.K. A quality assurance protocol for diffusion tensor imaging using the head phantom from American College of Radiology. Med Phys 2011, 38(7):4415-4421. 10.1118/1.3595111.
370. Mohammadi S., Nagy Z., Moller H.E., Symms M.R., Carmichael D.W., Josephs O., et al. The effect of local perturbation fields on human DTI: characterisation, measurement and correction. Neuroimage 2012, 60(1):562-570. 10.1016/j.neuroimage.2011.12.009.
371. De Santis S., Evans C.J., Jones D.K. RAPID: a routine assurance pipeline for imaging of diffusion. Magn Reson Med 2012, 10.1002/mrm.24465.
372. Walker L., Curry M., Nayak A., Lange N., Pierpaoli C. A framework for the analysis of phantom data in multicenter diffusion tensor imaging studies. Hum Brain Mapp 2013, 34(10):2439-2454. 10.1002/hbm.22081.
373. Lauzon C.B., Asman A.J., Esparza M.L., Burns S.S., Fan Q., Gao Y., et al. Simultaneous analysis and quality assurance for diffusion tensor imaging. PLoS One 2013, 8(4):e61737. 10.1371/journal.pone.0061737.
374. Malyarenko D., Galban C.J., Londy F.J., Meyer C.R., Johnson T.D., Rehemtulla A., et al. Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom. J Magn Reson Imaging 2013, 37(5):1238-1246. 10.1002/jmri.23825.
375. Giannelli M., Sghedoni R., Iacconi C., Iori M., Traino A.C., Guerrisi M., et al. MR scanner systems should be adequately characterized in diffusion-MRI of the breast. PLoS One 2014, 9(1):e86280. 10.1371/journal.pone.0086280.